Enifer Raises €36 Million for Factory Construction and Market Expansion
Enifer Raises €36M in Funding
Enifer's Funding and Factory Construction
Key Highlights:
- Funding Round: Enifer, a mycoprotein company based in Espoo, Finland, raised €36 million in funding.
- Series B Equity Funding: €15 million raised in a Series B funding round led by Taaleri Bioindustry Fund I, with participation from existing shareholders.
- Additional Funding: €7 million capital loan from the Finnish Climate Fund and a €2 million Climate and Environmental Loan from Finnvera.
- Factory Construction: Funds will be used to construct a food-grade mycoprotein factory in Kirkkonummi, Finland, capable of producing up to 3,000 tons of PEKILO® mycoprotein annually.
Enifer's Target Market
- Food and Feed Industries: Partnerships with global companies in the feed and food industries, including Skretting, Purina, and Valio.
- Consumer Food Products: Collaboration with Valio to develop mycoprotein-based consumer food products.
- Aquafeed Division: Partnership with Skretting, a global aquafeed division of Nutreco, to provide mycoprotein for aquafeed.
What Enifer Needs to Buy
- Factory Construction Services: Construction companies and contractors experienced in building food-grade production facilities.
- Research and Development Partnerships: Collaborations with research institutions and biotech companies to further develop and optimize the PEKILO® technology.
- Marketing and Distribution Support: Partnerships with distributors and marketing agencies to promote and distribute PEKILO® mycoprotein products.